EUVIMEDEUVIMED entdecken
Querschnittstudie

The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening: a nationwide cross-sectional study

Simon Ladefoged Rasmussen iD, Christian Torp-Pedersen, Kåre Andersson Gotschalck, Ole Thorlacius-Ussing

Endoscopy · 01.05.2023 · 55 (05) · 444-455

DOI: 10.1055/a-1992-5598 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Endoscopy, erschienen am 01.05.2023. Verfasst von Simon Ladefoged Rasmussen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Anticoagulants, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Program for Clinical Research Infrastructure (PROCRIN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Screening for colorectal cancer (CRC) using the fecal immunochemical test (FIT) has been widely adopted. The use of antithrombotic treatment is increasing in the Western world. This study aimed to assess the effects of antithrombotic treatment on the FIT-based Danish national screening program for CRC.

Methods

This was a cross-sectional study of all individuals returning a FIT from 2014 until 2016. The effect of antithrombotic treatment on FIT positivity and the positive predictive value (PPV) were assessed using proportions and multivariable Poisson regression.

Results

Of 884 036 invited individuals, we identified 551 570 participants. A positive FIT was observed in 9052 of 77 007 individuals (11.8 %) receiving antithrombotic treatment compared with 28 387 of 474 587 individuals (6.0 %) receiving no treatment. The adjusted relative risk (RR) for a positive FIT was 1.59 (95 %CI 1.56–1.63) for any treatment. Nonvitamin K oral anticoagulants (NOACs) were associated with the largest increase in FIT positivity (adjusted RR 2.40, 95 %CI 2.48–2.54). The proportion of CRC detected at colonoscopy was slightly lower among patients on antithrombotic treatment (6.0 %, 95 %CI 5.5 %–6.6 %) than among treatment-naïve patients (6.4 %, 95 %CI 6.1 %–6.7 %). The PPV for CRC or high risk adenomas was decreased nearly twofold in patients treated with NOAC (adjusted RR 0.58, 95 %CI 0.51–0.66]).

Conclusion

Antithrombotic treatment was associated with a decreased PPV in FIT-based CRC screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsColorectal NeoplasmsHumansCross-Sectional StudiesFibrinolytic AgentsAdministration, OralEarly Detection of CancerColonoscopyMass ScreeningOccult BloodFeces

Substanzen

AnticoagulantsFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark.
  • Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Clinical Investigation and Cardiology, Nordsjaellands Hospital Hillerød, Denmark.
  • Department of Surgery, The Regional Hospital, Horsens, Denmark.

ORCID-Profile: Simon Ladefoged Rasmussen

Förderung

  • Program for Clinical Research Infrastructure (PROCRIN)

Zitieren

APA

Rasmussen, S. L., Torp-Pedersen, C., Gotschalck, K. A., & Thorlacius-Ussing, O. (2023). The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening: a nationwide cross-sectional study. Endoscopy, 55(05), 444-455. https://doi.org/10.1055/a-1992-5598

Vancouver

Rasmussen SL, Torp-Pedersen C, Gotschalck KA, Thorlacius-Ussing O. The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening: a nationwide cross-sectional study. Endoscopy. 2023;55(05):444-455. doi:10.1055/a-1992-5598

BibTeX
@article{Rasmussen2023,
  author = {Rasmussen, Simon Ladefoged and Torp-Pedersen, Christian and Gotschalck, Kåre Andersson and Thorlacius-Ussing, Ole},
  title = {The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening: a nationwide cross-sectional study},
  journal = {Endoscopy},
  year = {2023},
  volume = {55},
  number = {05},
  pages = {444--455},
  doi = {10.1055/a-1992-5598}
}
Kostenlos starten →